Articles From: Lilly Announces Enzastaurin Phase III Study Did Not Meet Primary Endpoint in Diffuse Large B-Cell Lymphoma to Single Touch to Present at B. Riley & Co. Investor Conference on May 20th


2013/5/10
INDIANAPOLIS , May 10, 2013 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today Phase III clinical trial results from enzastaurin's PRELUDE study, which explored the molecule as a monotherapy in the prevention of relapse in patients with diffuse large B-cell lymphoma (DLBCL). The study failed to show a statistically significant increase compared to placebo in disease-free survival in patients at high risk of relapse following rituximab-based chemotherapy.
Sign-up for Lilly Announces Enzastaurin Phase III Study Did Not Meet Primary Endpoint in Diffuse Large B-Cell Lymphoma investment picks
2013/5/10
BALTIMORE , May 10, 2013 /PRNewswire/ -- Legg Mason, Inc. (NYSE: LM) reported preliminary assets under management of $655 billion as of April 30, 2013 .
Sign-up for Legg Mason Reports Assets Under Management For April 2013 investment picks
2013/5/10
Ivanhoe Energy Disputes Baseless Allegations in Recycled Law Suit filed over Ecuador Oilfield Development Contract Canada NewsWire CALGARY , May 10, 2013 /CNW/ - Ivanhoe Energy (TSX: IE; NASDAQ: IVAN) announced today that reported allegations contained in a recently filed lawsuit in Vancouver , British Columbia against Ivanhoe Energy, its subsidiaries Ivanhoe Energy Latin America and Ivanhoe Energy Ecuador and shareholder Robert Friedland , are false and without merit.
Sign-up for Ivanhoe Energy Disputes Baseless Allegations in Recycled Law Suit filed over Ecuador Oilfield Development Contract investment picks
2013/5/10
CALGARY , May 10, 2013 /PRNewswire/ - Ivanhoe Energy (TSX: IE; NASDAQ: IVAN) announced today that reported allegations contained in a recently filed lawsuit in Vancouver, British Columbia against Ivanhoe Energy, its subsidiaries Ivanhoe Energy Latin America and Ivanhoe Energy Ecuador and shareholder Robert Friedland , are false and without merit.
Sign-up for Ivanhoe Energy Disputes Baseless Allegations in Recycled Law Suit filed over Ecuador Oilfield Development Contract investment picks
2013/5/10
PHILADELPHIA , May 10, 2013 /PRNewswire/ -- Echo Therapeutics, Inc. (Nasdaq: ECTE) , a company developing its needle-free Symphony ® CGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system, today announced financial results for the quarter ended March 31 , 2013.
Sign-up for Echo Therapeutics Announces First Quarter 2013 Financial Results investment picks
2013/5/10
http://media.marketwire.com/attachments/201212/109000_36797_HP_Blue_RGB_72_MD.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1016012&ProfileId=051205&sourceType=1 PALO ALTO, CA --
Sign-up for HP Vertica Announces First Annual Worldwide User Conference investment picks
2013/5/10
http://media.marketwire.com/attachments/201204/39880_HP_Blue_RGB_72_MD.gif http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1014425&ProfileId=051205&sourceType=1 PALO ALTO, CA --
Sign-up for HP Announces Participation in Upcoming Investor Conferences investment picks
2013/5/10
http://media.marketwire.com/attachments/201204/39880_HP_Blue_RGB_72_MD.gif http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1014431&ProfileId=051205&sourceType=1 PALO ALTO, CA --
Sign-up for HP to Present Live Audio Webcast of Second Quarter Earnings Conference Call investment picks
2013/5/10
Wajax Announces 2013 First Quarter Results Canada NewsWire TSX Symbol:  WJX     (Dollars in millions, except per share data) Three Months Ended March 31   2013 2012 CONSOLIDATED RESULTS     Revenue $336.3 $358.1 Net earnings $10.4 $17.1 Basic earnings per share $0.62 $1.03       SEGMENTS     Revenue - Equipment     $167.4     $170.4   - Power Systems $79.9 $95.9   - Industrial Components $89.8 $93.3 Earnings - Equipment $9.9 $13.1     %  margin 5.9% 7.7%   - Power Systems $4.1 $8.7     %  margin 5.1% 9.1%   -
Sign-up for Wajax Announces 2013 First Quarter Results investment picks
2013/5/10
USA Technologies, Inc. (NASDAQ: USAT ), (“USAT”), a leader of wireless, cashless payment and M2M telemetry solutions for self-serve, small-ticket retail industries, today reported results for the third quarter of fiscal 2013 ended March 31, 2013.
Sign-up for USA Technologies Reports Financial Results for Third Quarter of Fiscal 2013 investment picks
2013/5/10
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1016021&ProfileId=051205&sourceType=1 SAN FRANCISCO, CA --
Sign-up for Dell and RainStor Team Up for Webcast on Big Data in Banking investment picks
2013/5/10
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G005041-001&sourceType=1 http://www.marketwire.com/library/MwGo/2013/5/9/11G005041/perma-fix_logo_with_nuc_services_high_res-443862070645.jpg ATLANTA, GA --(Marketwired - May 10, 2013) -  Perma-Fix Environmental Services, Inc. (NASDAQ: PESI) today announced results for the first quarter ended March 31, 2013.
Sign-up for Perma-Fix Announces Financial Results and Provides Business Update for the First Quarter of 2013 investment picks
2013/5/10
CUPERTINO, Calif.
Sign-up for DURECT Announces Update on Remoxy® investment picks
2013/5/10
LYNBROOK, N.Y. , May 10, 2013 /PRNewswire/ -- BioSpecifics Technologies Corp.
Sign-up for BioSpecifics Technologies Corp. Reports First Quarter 2013 Financial Results investment picks
2013/5/10
Novartis AG (NVS, NOVN.VX) said the U.S. Food and Drug Administration approved Ilaris for the treatment of active systemic juvenile idiopathic arthritis, a serious form of childhood arthritis.
Sign-up for Novartis: FDA Approves Ilaris for Serious Form of Childhood Arthritis investment picks
2013/5/10
DUBLIN, Ireland, May 10, 2013 (GLOBE NEWSWIRE) -- Warner Chilcott plc (Nasdaq:WCRX) today announced its results for the quarter ended March 31, 2013.
Sign-up for Warner Chilcott Reports Operating Results for the Quarter Ended March 31, 2013 investment picks
2013/5/10
TARRYTOWN, N.Y., May 10, 2013 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX) today announced its results of operations for the quarter ended March 31.
Sign-up for Progenics Pharmaceuticals Announces First Quarter 2013 Financial Results investment picks
2013/5/10
FT. LAUDERDALE, Fla.
Sign-up for iTalk Inc. Introduces Samsung Galaxy Tablet with built-in iData Mobile Broadband from iTalk investment picks
2013/5/10
WALL, N.J., May 10, 2013 (GLOBE NEWSWIRE) -- Student Transportation Inc. ("STI") (TSX:STB) (Nasdaq:STB) , North America's third-largest provider of school bus transportation services today released a Letter to Shareholders from Chairman and CEO Denis Gallagher in appreciation of the support for the Company's 100 th consecutive monthly dividend.
Sign-up for Student Transportation Inc. CEO Releases Letter to Shareholders investment picks
2013/5/10
Microgrids hold strong appeal for the United States Department of Defense (DOD). Microgrids can reduce the amount of fossil fuels consumed to create electricity by networking generators as a system, and can help integrate renewable energy resources (such as wind and solar) for military installations.
Sign-up for Microgrids for Military Bases to Surpass $377 Million in Annual Market Value by 2018, Forecasts Navigant Research investment picks
2013/5/10
LONDON --Commodities trading firm Vitol Group Friday said it has agreed to buy U.K. -based Immingham Combined Heat and Power, marking its first power plant purchase.
Sign-up for Vitol Makes First Power Plant Acquisition With UK Buy investment picks
2013/5/10
BEIJING -- Alibaba Group Holding Ltd.
Sign-up for UPDATE: Alibaba to Invest $294 Million in AutoNavi, Gets 28% Stake investment picks
2013/5/10
Pain Therapeutics Inc. (PTIE) said Pfizer Inc. (PFE) is evaluating its continued participation in the development of the pain-medicine candidate Remoxy and doesn't know when a final decision will be made.
Sign-up for Pain Therapeutics: Pfizer Reassessing Continued Remoxy Partnership investment picks
2013/5/10
Tessera Technologies, Inc. (NASDAQ: TSRA) (the “Company” or “we”) announced today that its Tessera, Inc. subsidiary has reached a settlement with Siliconware Precision Industries Co., Ltd.
Sign-up for Tessera and Siliconware Settle Litigation investment picks
2013/5/10
NEW YORK , May 10, 2013 /PRNewswire/ -- Life Care Medical Devices Ltd (OTCBB:LCMD) today announced the opening of their European subsidiary offices in Dublin , Ireland.
Sign-up for Life Care Medical Devices Ltd Announces Addition Of Dublin, Ireland Based European Subsidiary investment picks
2013/5/10
JAKARTA -- General Motors Co.
Sign-up for GM Eyes New Round of Expansion in Indonesia After Repening Plant -International President investment picks
2013/5/10
WASHINGTON (MarketWatch) — Stock markets are almost every day, leading to some tense debates about how much higher stock values can go.
Sign-up for It’s not just stocks; everything is overvalued investment picks
2013/5/10
Sirona (Nasdaq: SIRO) , the dental technology leader, today announced that the Company's Board of Directors has approved a new share repurchase program, authorizing up to an additional $100 million in share repurchases, with an expiration date of June 30, 2016.
Sign-up for Sirona Announces Additional $100 Million Share Repurchase Authorization investment picks
2013/5/10
Sirona (Nasdaq: SIRO) , the dental technology leader, today announced its financial results for the quarter ended March 31, 2013.
Sign-up for Sirona Reports Fiscal 2013 Second Quarter Results investment picks
2013/5/10
http://media.marketwire.com/attachments/201304/141800_57245_singletouchlogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1015532&ProfileId=051205&sourceType=1 JERSEY CITY, NJ --
Sign-up for Single Touch to Present at B. Riley & Co. Investor Conference on May 20th investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)
P   Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)
P   Morningstar Stock Analyst Reports (full research on 2,000 stocks)
P   Morningstar Stock and Fund Stewardship Grades
P   Portfolio Manager (advanced with 10 x-ray analyses, including guidance)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Lilly Announces Enzastaurin Phase III Study Did Not Meet Primary Endpoint in Diffuse Large B-Cell Lymphoma to Single Touch to Present at B. Riley & Co. Investor Conference on May 20th
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity